Provided by Tiger Trade Technology Pte. Ltd.

Verastem

6.86
-0.0300-0.44%
Pre-market: 6.940.0800+1.17%08:38 EDT
Volume:1.17M
Turnover:8.00M
Market Cap:621.27M
PE:-2.84
High:6.96
Open:6.90
Low:6.62
Close:6.89
52wk High:11.25
52wk Low:3.43
Shares:90.56M
Float Shares:70.57M
Volume Ratio:0.54
T/O Rate:1.65%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4143
EPS(LYR):-3.0223
ROE:-471.16%
ROA:-49.59%
PB:12.43
PE(LYR):-2.27

Loading ...

Verastem announces FDA Fast Track designation for VS-7375

TIPRANKS
·
Jun 04

Verastem wins FDA fast-track tag for VS-7375 in KRAS G12D-mutated advanced NSCLC after prior therapy

Reuters
·
Jun 04

Verastem - Initiates Phase 2 Target-D 202 Trial for Advanced Nsclc

THOMSON REUTERS
·
Jun 04

Verastem Oncology Announces U.S. FDA Fast Track Designation for VS-7375, an Oral and Potential Best-in-Class Investigational Kras G12d (on/off) Inhibitor for the Treatment of Kras G12d-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer

THOMSON REUTERS
·
Jun 04

Verastem files Form 3 initial beneficial ownership statement for director Michael P. Bailey

Reuters
·
May 28

Verastem Oncology to present at Jefferies Global Healthcare Conference fireside chat

Reuters
·
May 27

H.C. Wainwright Sticks to Their Buy Rating for Verastem (VSTM)

TIPRANKS
·
May 27

Verastum Oncology Appoints Michael P. Bailey to Its Board of Directors

Deep News
·
May 26

Verastem appoints Michael Bailey to board of directors

TIPRANKS
·
May 26

Verastem shareholders approve amended 2021 equity incentive plan at annual meeting

Reuters
·
May 26

Verastem Oncology appoints AVEO CEO Michael P. Bailey to board

Reuters
·
May 26

Verastem Oncology Appoints Michael P. Bailey to Its Board of Directors

THOMSON REUTERS
·
May 26

Verastem (VSTM) Receives a Buy from B. Riley Securities

TIPRANKS
·
May 22

Amap Traffic Light Countdown Feature Expands Internationally, Aiming for Global Coverage

Deep News
·
May 20

GenFleet GFH375 wins China breakthrough status for KRAS G12D pancreatic cancer therapy

Reuters
·
May 18

Verastem price target lowered to $14 from $16 at Mizuho

TIPRANKS
·
May 14

Analysts’ Top Healthcare Picks: Verastem (VSTM), PDS Biotechnology (PDSB)

TIPRANKS
·
May 13

Verastem Oncology to present at RBC Global Healthcare Conference

Reuters
·
May 12

Verastem Inc Earnings Call Highlights Growth And Risk

TIPRANKS
·
May 09

Verastem (VSTM) Q4 Revenue Reaches US$17.5 Million Yet Heavy Losses Reinforce Bearish Views

Simply Wall St.
·
May 09